Resources & Reports

Newsletter

DEA Flexibilities Extended Again➕ It’s Thanksgiving Week!!

As families gather around tables filled with tradition and gratitude, we’re reminded how much access—whether to food, warmth, community, or care—shapes our wellbeing. In the telehealth world, access takes many forms. Recently, we’ve seen this reflected not only in the extensions of the Medicare telehealth waivers, but also in the DEA’s ongoing efforts to extend flexibilities around the in-person requirement for prescribing controlled substances. Once again, continued access to essential telemedicine services is at the forefront.

Newsletter

MEDICARE TELEHEALTH WAIVERS EXTENDED (…for now, anyway!)

Last week, after agreeing to a deal to end the federal government shutdown, Congress passed a continuing resolution that would reopen the government, at least through January 30, 2026.  Within the continuing resolution package was an extension of the Medicare telehealth waivers, which had previously expired on October 1, 2025 (NOTE: The package contained several divisions, however the link provided in this newsletter only goes to the section containing the telehealth items).  In the passed legislation, the telehealth waivers that had expired will now be extended through January 30, 2026.